InspireMD (NSPR) Competitors $2.50 0.00 (0.00%) Closing price 04:00 PM EasternExtended Trading$2.51 +0.01 (+0.40%) As of 04:21 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NSPR vs. TMCI, DCTH, SNWV, BFLY, CLPT, NPCE, RXST, DRTS, CATX, and TCMDShould you be buying InspireMD stock or one of its competitors? The main competitors of InspireMD include Treace Medical Concepts (TMCI), Delcath Systems (DCTH), Sanuwave Health (SNWV), Butterfly Network (BFLY), ClearPoint Neuro (CLPT), NeuroPace (NPCE), RxSight (RXST), Alpha Tau Medical (DRTS), Perspective Therapeutics (CATX), and Tactile Systems Technology (TCMD). These companies are all part of the "medical equipment" industry. InspireMD vs. Its Competitors Treace Medical Concepts Delcath Systems Sanuwave Health Butterfly Network ClearPoint Neuro NeuroPace RxSight Alpha Tau Medical Perspective Therapeutics Tactile Systems Technology Treace Medical Concepts (NASDAQ:TMCI) and InspireMD (NYSE:NSPR) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, media sentiment, dividends, risk, profitability, valuation and earnings. Is TMCI or NSPR more profitable? Treace Medical Concepts has a net margin of -23.01% compared to InspireMD's net margin of -413.96%. Treace Medical Concepts' return on equity of -46.76% beat InspireMD's return on equity.Company Net Margins Return on Equity Return on Assets Treace Medical Concepts-23.01% -46.76% -23.35% InspireMD -413.96%-69.42%-57.68% Which has more volatility & risk, TMCI or NSPR? Treace Medical Concepts has a beta of 0.68, indicating that its stock price is 32% less volatile than the S&P 500. Comparatively, InspireMD has a beta of 0.6, indicating that its stock price is 40% less volatile than the S&P 500. Do analysts rate TMCI or NSPR? Treace Medical Concepts presently has a consensus price target of $9.83, indicating a potential upside of 42.72%. InspireMD has a consensus price target of $4.50, indicating a potential upside of 80.00%. Given InspireMD's stronger consensus rating and higher probable upside, analysts clearly believe InspireMD is more favorable than Treace Medical Concepts.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Treace Medical Concepts 0 Sell rating(s) 4 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33InspireMD 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has preferable valuation & earnings, TMCI or NSPR? InspireMD has lower revenue, but higher earnings than Treace Medical Concepts. Treace Medical Concepts is trading at a lower price-to-earnings ratio than InspireMD, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTreace Medical Concepts$209.36M2.08-$55.74M-$0.79-8.72InspireMD$7.07M14.76-$19.92M-$0.83-3.01 Does the media refer more to TMCI or NSPR? In the previous week, Treace Medical Concepts had 9 more articles in the media than InspireMD. MarketBeat recorded 10 mentions for Treace Medical Concepts and 1 mentions for InspireMD. InspireMD's average media sentiment score of 0.95 beat Treace Medical Concepts' score of 0.11 indicating that InspireMD is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Treace Medical Concepts 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 3 Negative mention(s) 1 Very Negative mention(s) Neutral InspireMD 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders & institutionals have more ownership in TMCI or NSPR? 84.1% of Treace Medical Concepts shares are owned by institutional investors. Comparatively, 44.8% of InspireMD shares are owned by institutional investors. 27.7% of Treace Medical Concepts shares are owned by insiders. Comparatively, 34.1% of InspireMD shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. SummaryTreace Medical Concepts beats InspireMD on 8 of the 15 factors compared between the two stocks. Get InspireMD News Delivered to You Automatically Sign up to receive the latest news and ratings for NSPR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NSPR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NSPR vs. The Competition Export to ExcelMetricInspireMDSurgical & medical instruments IndustryMedical SectorNYSE ExchangeMarket Cap$104.30M$75.30M$5.68B$20.90BDividend YieldN/AN/A4.61%3.57%P/E Ratio-3.3310.3430.6828.03Price / Sales14.7686.74464.1054.84Price / CashN/A18.4138.2123.95Price / Book1.377.428.995.23Net Income-$19.92M-$25.86M$3.25B$994.11M7 Day Performance3.31%1.69%4.78%1.77%1 Month Performance8.70%7.16%6.80%2.02%1 Year Performance-15.54%49.67%30.61%12.78% InspireMD Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NSPRInspireMD3.5856 of 5 stars$2.50flat$4.50+80.0%-13.8%$104.30M$7.07M-3.3350TMCITreace Medical Concepts2.3597 of 5 stars$6.39+4.2%$9.83+53.9%+27.1%$387.25M$209.36M-8.09250DCTHDelcath Systems2.6885 of 5 stars$10.51+5.0%$24.50+133.1%+42.3%$350.16M$37.21M210.2060Short Interest ↑SNWVSanuwave Health2.5331 of 5 stars$42.74+7.5%$49.00+14.6%N/A$340.66M$32.63M-5.1840Earnings ReportHigh Trading VolumeBFLYButterfly Network2.5137 of 5 stars$1.37+2.6%$3.00+119.8%+50.4%$334.82M$82.06M-4.88460CLPTClearPoint Neuro1.7258 of 5 stars$10.60-2.0%$19.67+85.5%+18.8%$302.84M$31.39M-13.95110News CoverageEarnings ReportAnalyst RevisionNPCENeuroPace3.1568 of 5 stars$8.89-1.0%$17.00+91.2%+33.4%$294.53M$79.91M-10.58170News CoverageEarnings ReportAnalyst ForecastShort Interest ↑Analyst RevisionRXSTRxSight1.5087 of 5 stars$6.65-7.5%$10.00+50.4%-83.9%$294.19M$139.93M-8.31220Trending NewsShort Interest ↑DRTSAlpha Tau Medical2.5914 of 5 stars$3.56+5.0%$8.00+124.7%+51.7%$287.54MN/A-7.7480News CoverageEarnings ReportAnalyst RevisionHigh Trading VolumeCATXPerspective Therapeutics1.6878 of 5 stars$3.72+1.1%$12.56+237.5%-70.8%$276.13MN/A0.0070Analyst RevisionTCMDTactile Systems Technology2.6659 of 5 stars$12.17-0.9%$13.50+10.9%-1.5%$273.75M$292.98M19.631,037 Related Companies and Tools Related Companies TMCI Competitors DCTH Competitors SNWV Competitors BFLY Competitors CLPT Competitors NPCE Competitors RXST Competitors DRTS Competitors CATX Competitors TCMD Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:NSPR) was last updated on 8/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InspireMD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share InspireMD With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access